Optimize Risk Prediction After Myocardial Infarction: The ORACLE Study

RecruitingOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

February 29, 2028

Conditions
Myocardial Infarction (MI)
Interventions
OTHER

data collection

"The ORACLE program is a prospective, deep phenotyping, study based on multimodal information and artificial intelligence computation. We will prospectively collect in-hospital and out-of-hospital data of a large cohort of patients presenting with MI, including data from wearable devices recording continuous ECG, interstitial-fluids, non-invasive blood pressure and mobility, behavioural patterns from a dedicated mobile application, blood and urine biomarkers and non-invasive imaging. We will leverage on AI, using statistical learning methods and neural networks, to explore patterns and higher order interactions within the data to provide novel computational biomarkers of ischemic and bleeding risk."

Trial Locations (1)

29010

RECRUITING

Hospital Universitario Virgen de la Victoria, Málaga

All Listed Sponsors
collaborator

European Research Council

OTHER

lead

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

OTHER